(The Epoch Times)—The share of health care personnel recommending COVID-19 jabs and other vaccines to patients has declined significantly in recent years, with overall trust in the U.S. Centers for Disease Control and Prevention (CDC) declining, according to a recent study.
The peer-reviewed study, published in the journal NPJ Vaccines on Feb. 28, examined how vaccine attitudes and recommendations changed among health care personnel (HCP) during the COVID-19 pandemic. Researchers conducted a survey in January 2023 and compared the results with an earlier survey from September 2021, finding that health care personnel recommendations for vaccines “decreased substantially for nearly all vaccines and patient populations.”
In addition, trust in the CDC “decreased [from 79 to 73 percent], as did support for HCP COVID-19 vaccine mandates [from 65 to 46 percent].”
“This is concerning as HCP have long been the most frequently used and credible source of vaccine information, especially given public suspicion of vaccine information from pharmaceutical companies and government, and encouragement from HCP is strongly associated with patients vaccinating against COVID-19,” said the study.
Researchers found that health care personnel not vaccinated against COVID-19 were “far less likely to recommend vaccinating to their patients.” And even in the case of vaccinated personnel, they required regularly updated resources “to confidently discuss vaccines with hesitant patients.”
Study Participants
The study was conducted among 1,207 participants made up of four types of health care personnel—pediatricians; family medicine doctors; physicians assistants, nurse practitioners, and nurses; and pharmacists. Almost all personnel (96 percent) had received at least one COVID-19 vaccine, with 82 percent taking booster shots.
The most frequently boosted personnel were pediatricians, followed by family medicine doctors, pharmacists, and nurses. Almost three-quarters of respondents had high trust in the CDC, which was found to be critical with regard to receiving COVID-19 vaccines.
“Most HCP with high trust in CDC [90 percent] were boosted, compared to [61 percent] of HCP with low trust in CDC,” the study said, adding that those with high trust in the CDC were nearly six times as likely to be boosted compared to those with low trust in the CDC.
- Hand-curated links from conservative and Christian sites — NO legacy media garbage links. Patriots get their news every day at JDRucker.com
Among those surveyed, 46 percent supported COVID-19 vaccine mandates for health care personnel, with supporters observed to be much more frequent among the boosted population. Among the 218 health care personnel who had not yet taken the booster shot, the most common reason was concern about side effects, with 44 percent citing this issue.
Other major reasons cited included the speed of vaccine development and approval (27 percent), low risk of infection (27 percent), and discomfort with the Emergency Use Authorization (24 percent).
Over half the personnel said that a key challenge to vaccinating patients against COVID-19 was the concern raised by the patients. Sixty-four percent pointed to patient concerns about the necessity of vaccines, 60 percent to the safety, and 54 percent about the effectiveness of the jabs.
Health care personnel who had received booster shots recommended three brands of COVID-19 vaccines more frequently than those who had not been boosted: Pfizer-BioNTech (38 percent of boosted versus 12 percent not boosted), Moderna (46 percent versus 11 percent), and Johnson & Johnson (8 percent versus 2 percent).
The study was conducted by five researchers based in the United States, out of which four declared competing interests.
Two of them received research support from Merck, with one serving on the advisory boards of Merck, Janssen, Sanofi, and Moderna. Both received funding from the Vaccination Confidence Fund, which is jointly funded by Facebook and Merck.
A third researcher serves as a consultant to Pfizer on meningococcal B vaccine. The fourth individual is a paid health advisor to the University of Roehampton, which provided guidance on pandemic recovery and preparedness, including views on vaccines, to the Group of Seven leading industrialized nations.
Vaccine Mandates for Health Care Workers
Health care workers were subjected to rigorous COVID-19 rules during the pandemic. In 2021, the Centers for Medicare & Medicaid Services (CMS) issued a rule mandating all American health care workers be vaccinated, which applied to about 76,000 health care providers covering roughly 17 million workers.
Health care workers protested the mandate. The Pennsylvania Health Care Association warned that the Biden administration’s proposal had the “potential to exacerbate an existing workforce crisis and jeopardize access to care for tens of thousands of vulnerable residents.”
“After seventeen months of providing tireless care at the epicenter of the COVID-19 pandemic, long-term care continues to face a troubling trend of federal and state governments threatening and punishing the same healthcare heroes they once supported and rallied behind,” it stated.
In 2022, the U.S. Supreme Court allowed the Biden administration to continue imposing COVID-19 vaccination requirements on most health care workers who were employed at places receiving funding from Medicaid and Medicare.
There are multiple studies among health care workers showing adverse effects following COVID-19 vaccination. A 2022 study on health care employees in Iraq found adverse events among vaccinated workers.
“The adverse effects associated with the Pfizer vaccine were significantly more prevalent in females than in males. Following the first dose, the participants experienced more adverse effects with the AstraZeneca vaccine. Following the second dose, more adverse effects were associated with the Pfizer vaccine,” it stated.
Another study among health care workers published in February 2024 found that 84.6 percent suffered at least one side effect after the first dose of a COVID-19 vaccine. Some of these side effects included headaches, muscle pain, and chills.
A recently published study in the International Journal of Vaccine Theory, Practice, and Research found links between vaccine hesitancy among individuals and their knowledge of vaccinated people affected by side effects.
“Knowing someone who experienced a health problem following COVID-19 injection reduced the likelihood of injection,” the study stated. Such individuals “were more likely to oppose injection mandates and passports.”
Among those who were aware of at least one person who experienced COVID-19 injection adverse events, they said they knew about 57 deaths following vaccination.
“The health issues reported ranged from serious problems such as cardiac arrests and other heart-related problems, blood clots and other circulatory problems, to neurological issues, as well as milder effects such as feeling sick, headache, fever, etc.”
Bypass Big Tech Censors
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.